| Overall | PSY, N(%) | BUP, N(%) | P-value | |
---|---|---|---|---|---|
 |  | 7,675 (69.0) | 3,443 (31.0) |  | |
Age, mean (SD) | 28.5 (4.8) | 28.6 (4.7) | 28.4 (4.8) | 0.05 | |
Age, Under 30 vs. ≥ 30 | 6,718 (60.4) | 4,599 (59.9) | 2,119 (61.6) | 0.11 | |
Race/Ethnicity | Â | Â | Â | Â | |
 Missing | 832 (7.5) | 474 (6.2) | 358 (10.4) | < 0.001 | |
 Non-Hispanic White | 9,049 (81.4) | 6,442 (83.9) | 2,607 (75.7) |  | |
 Non-Hispanic Black | 766 (6.9) | 558 (7.3) | 208 (6.0) |  | |
 Hispanic | 187 (1.7) | 81 (1.1) | 106 (3.1) |  | |
 Other | 284 (2.6) | 120 (1.6) | 164 (4.8) |  | |
Contraception Characteristics | |||||
Any Contraception at 90 days Postpartum | 2,487 (22.4) | 1,649 (21.5) | 838 (24.3) | < 0.001 | |
Contraception Subtypes at 90 days |  |  |  | < 0.001 | |
Prescription (effective) | Â | Â | Â | Â | |
 Patch | 25 (0.2) | 8 (0.1) | 17 (0.5) |  | |
 Ring | 118 (1.1) | 41 (0.5) | 77 (2.2) |  | |
 Oral contraceptive pills | 213 (1.9) | 71 (0.9) | 142 (4.1) |  | |
Provider-Administered (effective) | Â | Â | Â | Â | |
 Injection | 430 (3.9) | 324 (4.2) | 106 (3.1) |  | |
Provider-Administered (highly effective) | Â | Â | Â | Â | |
 Long-acting reversible contraception | 1,022 (9.2) | 734 (9.6) | 288 (8.4) |  | |
 Female sterilization | 679 (6.1) | 471 (6.1) | 208 (6.0) |  | |
Co-Occurring Conditions | |||||
Alcohol Use Disorder | 1,115 (10.0) | 894 (11.7) | 221 (6.4) | < 0.001 | |
Stimulant Use Disorder | 2,845 (25.6) | 2,244 (29.2) | 601 (17.5) | < 0.001 | |
Sedative Use Disorder | 839 (7.6) | 639 (8.3) | 200 (5.8) | < 0.001 | |
Anxiety Disorder | 4,369 (39.3) | 3,193 (41.6) | 1,176 (34.2) | < 0.001 | |
Mood Disorder | 4,155 (37.4) | 3,076 (40.1) | 1,079 (31.3) | < 0.001 | |
Insomnia | 534 (4.8) | 404 (5.3) | 130 (3.8) | < 0.001 | |
Migraine | 395 (3.6) | 289 (3.8) | 106 (3.1) | < 0.001 | |
Chronic Pain | 568 (5.1) | 350 (4.6) | 218 (6.3) | < 0.001 |